Medical Care
Global Organoid Biobank Market Research Report 2025
- May 12, 25
- ID: 235378
- Pages: 97
- Figures: 96
- Views: 33
The global market for Organoid Biobank was valued at US$ 164 million in the year 2024 and is projected to reach a revised size of US$ 531 million by 2031, growing at a CAGR of 18.5% during the forecast period.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
This report aims to provide a comprehensive presentation of the global market for Organoid Biobank, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoid Biobank.
The Organoid Biobank market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organoid Biobank market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoid Biobank companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoid Biobank company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
This report aims to provide a comprehensive presentation of the global market for Organoid Biobank, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoid Biobank.
The Organoid Biobank market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organoid Biobank market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoid Biobank companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoid Biobank company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoid Biobank Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Derived Organoids
1.2.3 Pluripotent Stem Cell-derived Organoids
1.3 Market by Application
1.3.1 Global Organoid Biobank Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Research Organizations
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoid Biobank Market Perspective (2020-2031)
2.2 Global Organoid Biobank Growth Trends by Region
2.2.1 Global Organoid Biobank Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Organoid Biobank Historic Market Size by Region (2020-2025)
2.2.3 Organoid Biobank Forecasted Market Size by Region (2026-2031)
2.3 Organoid Biobank Market Dynamics
2.3.1 Organoid Biobank Industry Trends
2.3.2 Organoid Biobank Market Drivers
2.3.3 Organoid Biobank Market Challenges
2.3.4 Organoid Biobank Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoid Biobank Players by Revenue
3.1.1 Global Top Organoid Biobank Players by Revenue (2020-2025)
3.1.2 Global Organoid Biobank Revenue Market Share by Players (2020-2025)
3.2 Global Organoid Biobank Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Organoid Biobank Revenue
3.4 Global Organoid Biobank Market Concentration Ratio
3.4.1 Global Organoid Biobank Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoid Biobank Revenue in 2024
3.5 Global Key Players of Organoid Biobank Head office and Area Served
3.6 Global Key Players of Organoid Biobank, Product and Application
3.7 Global Key Players of Organoid Biobank, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoid Biobank Breakdown Data by Type
4.1 Global Organoid Biobank Historic Market Size by Type (2020-2025)
4.2 Global Organoid Biobank Forecasted Market Size by Type (2026-2031)
5 Organoid Biobank Breakdown Data by Application
5.1 Global Organoid Biobank Historic Market Size by Application (2020-2025)
5.2 Global Organoid Biobank Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Organoid Biobank Market Size (2020-2031)
6.2 North America Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Organoid Biobank Market Size by Country (2020-2025)
6.4 North America Organoid Biobank Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoid Biobank Market Size (2020-2031)
7.2 Europe Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Organoid Biobank Market Size by Country (2020-2025)
7.4 Europe Organoid Biobank Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoid Biobank Market Size (2020-2031)
8.2 Asia-Pacific Organoid Biobank Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Organoid Biobank Market Size by Region (2020-2025)
8.4 Asia-Pacific Organoid Biobank Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoid Biobank Market Size (2020-2031)
9.2 Latin America Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Organoid Biobank Market Size by Country (2020-2025)
9.4 Latin America Organoid Biobank Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoid Biobank Market Size (2020-2031)
10.2 Middle East & Africa Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Organoid Biobank Market Size by Country (2020-2025)
10.4 Middle East & Africa Organoid Biobank Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FRANKFURT CANCER INSTITUTE
11.1.1 FRANKFURT CANCER INSTITUTE Company Details
11.1.2 FRANKFURT CANCER INSTITUTE Business Overview
11.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Introduction
11.1.4 FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2020-2025)
11.1.5 FRANKFURT CANCER INSTITUTE Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Organoid Biobank Introduction
11.2.4 Merck Revenue in Organoid Biobank Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Details
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Organoid Biobank Introduction
11.3.4 Crown Bioscience Revenue in Organoid Biobank Business (2020-2025)
11.3.5 Crown Bioscience Recent Development
11.4 HUB Organoids
11.4.1 HUB Organoids Company Details
11.4.2 HUB Organoids Business Overview
11.4.3 HUB Organoids Organoid Biobank Introduction
11.4.4 HUB Organoids Revenue in Organoid Biobank Business (2020-2025)
11.4.5 HUB Organoids Recent Development
11.5 Cancer Research UK Convergence Science Centre
11.5.1 Cancer Research UK Convergence Science Centre Company Details
11.5.2 Cancer Research UK Convergence Science Centre Business Overview
11.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Introduction
11.5.4 Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2020-2025)
11.5.5 Cancer Research UK Convergence Science Centre Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Organoid Biobank Introduction
11.6.4 Thermo Fisher Scientific Revenue in Organoid Biobank Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Corning
11.7.1 Corning Company Details
11.7.2 Corning Business Overview
11.7.3 Corning Organoid Biobank Introduction
11.7.4 Corning Revenue in Organoid Biobank Business (2020-2025)
11.7.5 Corning Recent Development
11.8 STEMCELL Technologies
11.8.1 STEMCELL Technologies Company Details
11.8.2 STEMCELL Technologies Business Overview
11.8.3 STEMCELL Technologies Organoid Biobank Introduction
11.8.4 STEMCELL Technologies Revenue in Organoid Biobank Business (2020-2025)
11.8.5 STEMCELL Technologies Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Organoid Biobank Introduction
11.9.4 Lonza Revenue in Organoid Biobank Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 Prellis Biologics
11.10.1 Prellis Biologics Company Details
11.10.2 Prellis Biologics Business Overview
11.10.3 Prellis Biologics Organoid Biobank Introduction
11.10.4 Prellis Biologics Revenue in Organoid Biobank Business (2020-2025)
11.10.5 Prellis Biologics Recent Development
11.11 Amsbio
11.11.1 Amsbio Company Details
11.11.2 Amsbio Business Overview
11.11.3 Amsbio Organoid Biobank Introduction
11.11.4 Amsbio Revenue in Organoid Biobank Business (2020-2025)
11.11.5 Amsbio Recent Development
11.12 Cellesce
11.12.1 Cellesce Company Details
11.12.2 Cellesce Business Overview
11.12.3 Cellesce Organoid Biobank Introduction
11.12.4 Cellesce Revenue in Organoid Biobank Business (2020-2025)
11.12.5 Cellesce Recent Development
11.13 DefiniGEN
11.13.1 DefiniGEN Company Details
11.13.2 DefiniGEN Business Overview
11.13.3 DefiniGEN Organoid Biobank Introduction
11.13.4 DefiniGEN Revenue in Organoid Biobank Business (2020-2025)
11.13.5 DefiniGEN Recent Development
11.14 3Dnamics Inc.
11.14.1 3Dnamics Inc. Company Details
11.14.2 3Dnamics Inc. Business Overview
11.14.3 3Dnamics Inc. Organoid Biobank Introduction
11.14.4 3Dnamics Inc. Revenue in Organoid Biobank Business (2020-2025)
11.14.5 3Dnamics Inc. Recent Development
11.15 Organoid Therapeutics
11.15.1 Organoid Therapeutics Company Details
11.15.2 Organoid Therapeutics Business Overview
11.15.3 Organoid Therapeutics Organoid Biobank Introduction
11.15.4 Organoid Therapeutics Revenue in Organoid Biobank Business (2020-2025)
11.15.5 Organoid Therapeutics Recent Development
11.16 InSphero
11.16.1 InSphero Company Details
11.16.2 InSphero Business Overview
11.16.3 InSphero Organoid Biobank Introduction
11.16.4 InSphero Revenue in Organoid Biobank Business (2020-2025)
11.16.5 InSphero Recent Development
11.17 AIVITA Biomedical
11.17.1 AIVITA Biomedical Company Details
11.17.2 AIVITA Biomedical Business Overview
11.17.3 AIVITA Biomedical Organoid Biobank Introduction
11.17.4 AIVITA Biomedical Revenue in Organoid Biobank Business (2020-2025)
11.17.5 AIVITA Biomedical Recent Development
11.18 JangoBio
11.18.1 JangoBio Company Details
11.18.2 JangoBio Business Overview
11.18.3 JangoBio Organoid Biobank Introduction
11.18.4 JangoBio Revenue in Organoid Biobank Business (2020-2025)
11.18.5 JangoBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoid Biobank Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Derived Organoids
1.2.3 Pluripotent Stem Cell-derived Organoids
1.3 Market by Application
1.3.1 Global Organoid Biobank Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Research Organizations
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoid Biobank Market Perspective (2020-2031)
2.2 Global Organoid Biobank Growth Trends by Region
2.2.1 Global Organoid Biobank Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Organoid Biobank Historic Market Size by Region (2020-2025)
2.2.3 Organoid Biobank Forecasted Market Size by Region (2026-2031)
2.3 Organoid Biobank Market Dynamics
2.3.1 Organoid Biobank Industry Trends
2.3.2 Organoid Biobank Market Drivers
2.3.3 Organoid Biobank Market Challenges
2.3.4 Organoid Biobank Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoid Biobank Players by Revenue
3.1.1 Global Top Organoid Biobank Players by Revenue (2020-2025)
3.1.2 Global Organoid Biobank Revenue Market Share by Players (2020-2025)
3.2 Global Organoid Biobank Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Organoid Biobank Revenue
3.4 Global Organoid Biobank Market Concentration Ratio
3.4.1 Global Organoid Biobank Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoid Biobank Revenue in 2024
3.5 Global Key Players of Organoid Biobank Head office and Area Served
3.6 Global Key Players of Organoid Biobank, Product and Application
3.7 Global Key Players of Organoid Biobank, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoid Biobank Breakdown Data by Type
4.1 Global Organoid Biobank Historic Market Size by Type (2020-2025)
4.2 Global Organoid Biobank Forecasted Market Size by Type (2026-2031)
5 Organoid Biobank Breakdown Data by Application
5.1 Global Organoid Biobank Historic Market Size by Application (2020-2025)
5.2 Global Organoid Biobank Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Organoid Biobank Market Size (2020-2031)
6.2 North America Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Organoid Biobank Market Size by Country (2020-2025)
6.4 North America Organoid Biobank Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoid Biobank Market Size (2020-2031)
7.2 Europe Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Organoid Biobank Market Size by Country (2020-2025)
7.4 Europe Organoid Biobank Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoid Biobank Market Size (2020-2031)
8.2 Asia-Pacific Organoid Biobank Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Organoid Biobank Market Size by Region (2020-2025)
8.4 Asia-Pacific Organoid Biobank Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoid Biobank Market Size (2020-2031)
9.2 Latin America Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Organoid Biobank Market Size by Country (2020-2025)
9.4 Latin America Organoid Biobank Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoid Biobank Market Size (2020-2031)
10.2 Middle East & Africa Organoid Biobank Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Organoid Biobank Market Size by Country (2020-2025)
10.4 Middle East & Africa Organoid Biobank Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FRANKFURT CANCER INSTITUTE
11.1.1 FRANKFURT CANCER INSTITUTE Company Details
11.1.2 FRANKFURT CANCER INSTITUTE Business Overview
11.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Introduction
11.1.4 FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2020-2025)
11.1.5 FRANKFURT CANCER INSTITUTE Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Organoid Biobank Introduction
11.2.4 Merck Revenue in Organoid Biobank Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Details
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Organoid Biobank Introduction
11.3.4 Crown Bioscience Revenue in Organoid Biobank Business (2020-2025)
11.3.5 Crown Bioscience Recent Development
11.4 HUB Organoids
11.4.1 HUB Organoids Company Details
11.4.2 HUB Organoids Business Overview
11.4.3 HUB Organoids Organoid Biobank Introduction
11.4.4 HUB Organoids Revenue in Organoid Biobank Business (2020-2025)
11.4.5 HUB Organoids Recent Development
11.5 Cancer Research UK Convergence Science Centre
11.5.1 Cancer Research UK Convergence Science Centre Company Details
11.5.2 Cancer Research UK Convergence Science Centre Business Overview
11.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Introduction
11.5.4 Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2020-2025)
11.5.5 Cancer Research UK Convergence Science Centre Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Organoid Biobank Introduction
11.6.4 Thermo Fisher Scientific Revenue in Organoid Biobank Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Corning
11.7.1 Corning Company Details
11.7.2 Corning Business Overview
11.7.3 Corning Organoid Biobank Introduction
11.7.4 Corning Revenue in Organoid Biobank Business (2020-2025)
11.7.5 Corning Recent Development
11.8 STEMCELL Technologies
11.8.1 STEMCELL Technologies Company Details
11.8.2 STEMCELL Technologies Business Overview
11.8.3 STEMCELL Technologies Organoid Biobank Introduction
11.8.4 STEMCELL Technologies Revenue in Organoid Biobank Business (2020-2025)
11.8.5 STEMCELL Technologies Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Organoid Biobank Introduction
11.9.4 Lonza Revenue in Organoid Biobank Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 Prellis Biologics
11.10.1 Prellis Biologics Company Details
11.10.2 Prellis Biologics Business Overview
11.10.3 Prellis Biologics Organoid Biobank Introduction
11.10.4 Prellis Biologics Revenue in Organoid Biobank Business (2020-2025)
11.10.5 Prellis Biologics Recent Development
11.11 Amsbio
11.11.1 Amsbio Company Details
11.11.2 Amsbio Business Overview
11.11.3 Amsbio Organoid Biobank Introduction
11.11.4 Amsbio Revenue in Organoid Biobank Business (2020-2025)
11.11.5 Amsbio Recent Development
11.12 Cellesce
11.12.1 Cellesce Company Details
11.12.2 Cellesce Business Overview
11.12.3 Cellesce Organoid Biobank Introduction
11.12.4 Cellesce Revenue in Organoid Biobank Business (2020-2025)
11.12.5 Cellesce Recent Development
11.13 DefiniGEN
11.13.1 DefiniGEN Company Details
11.13.2 DefiniGEN Business Overview
11.13.3 DefiniGEN Organoid Biobank Introduction
11.13.4 DefiniGEN Revenue in Organoid Biobank Business (2020-2025)
11.13.5 DefiniGEN Recent Development
11.14 3Dnamics Inc.
11.14.1 3Dnamics Inc. Company Details
11.14.2 3Dnamics Inc. Business Overview
11.14.3 3Dnamics Inc. Organoid Biobank Introduction
11.14.4 3Dnamics Inc. Revenue in Organoid Biobank Business (2020-2025)
11.14.5 3Dnamics Inc. Recent Development
11.15 Organoid Therapeutics
11.15.1 Organoid Therapeutics Company Details
11.15.2 Organoid Therapeutics Business Overview
11.15.3 Organoid Therapeutics Organoid Biobank Introduction
11.15.4 Organoid Therapeutics Revenue in Organoid Biobank Business (2020-2025)
11.15.5 Organoid Therapeutics Recent Development
11.16 InSphero
11.16.1 InSphero Company Details
11.16.2 InSphero Business Overview
11.16.3 InSphero Organoid Biobank Introduction
11.16.4 InSphero Revenue in Organoid Biobank Business (2020-2025)
11.16.5 InSphero Recent Development
11.17 AIVITA Biomedical
11.17.1 AIVITA Biomedical Company Details
11.17.2 AIVITA Biomedical Business Overview
11.17.3 AIVITA Biomedical Organoid Biobank Introduction
11.17.4 AIVITA Biomedical Revenue in Organoid Biobank Business (2020-2025)
11.17.5 AIVITA Biomedical Recent Development
11.18 JangoBio
11.18.1 JangoBio Company Details
11.18.2 JangoBio Business Overview
11.18.3 JangoBio Organoid Biobank Introduction
11.18.4 JangoBio Revenue in Organoid Biobank Business (2020-2025)
11.18.5 JangoBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Organoid Biobank Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tissue Derived Organoids
Table 3. Key Players of Pluripotent Stem Cell-derived Organoids
Table 4. Global Organoid Biobank Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Organoid Biobank Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Organoid Biobank Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Organoid Biobank Market Share by Region (2020-2025)
Table 8. Global Organoid Biobank Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Organoid Biobank Market Share by Region (2026-2031)
Table 10. Organoid Biobank Market Trends
Table 11. Organoid Biobank Market Drivers
Table 12. Organoid Biobank Market Challenges
Table 13. Organoid Biobank Market Restraints
Table 14. Global Organoid Biobank Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Organoid Biobank Market Share by Players (2020-2025)
Table 16. Global Top Organoid Biobank Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2024)
Table 17. Ranking of Global Top Organoid Biobank Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Organoid Biobank Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Organoid Biobank, Headquarters and Area Served
Table 20. Global Key Players of Organoid Biobank, Product and Application
Table 21. Global Key Players of Organoid Biobank, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Organoid Biobank Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Organoid Biobank Revenue Market Share by Type (2020-2025)
Table 25. Global Organoid Biobank Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Organoid Biobank Revenue Market Share by Type (2026-2031)
Table 27. Global Organoid Biobank Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Organoid Biobank Revenue Market Share by Application (2020-2025)
Table 29. Global Organoid Biobank Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Organoid Biobank Revenue Market Share by Application (2026-2031)
Table 31. North America Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Organoid Biobank Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Organoid Biobank Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Organoid Biobank Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 46. FRANKFURT CANCER INSTITUTE Company Details
Table 47. FRANKFURT CANCER INSTITUTE Business Overview
Table 48. FRANKFURT CANCER INSTITUTE Organoid Biobank Product
Table 49. FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 50. FRANKFURT CANCER INSTITUTE Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Organoid Biobank Product
Table 54. Merck Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Crown Bioscience Company Details
Table 57. Crown Bioscience Business Overview
Table 58. Crown Bioscience Organoid Biobank Product
Table 59. Crown Bioscience Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 60. Crown Bioscience Recent Development
Table 61. HUB Organoids Company Details
Table 62. HUB Organoids Business Overview
Table 63. HUB Organoids Organoid Biobank Product
Table 64. HUB Organoids Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 65. HUB Organoids Recent Development
Table 66. Cancer Research UK Convergence Science Centre Company Details
Table 67. Cancer Research UK Convergence Science Centre Business Overview
Table 68. Cancer Research UK Convergence Science Centre Organoid Biobank Product
Table 69. Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 70. Cancer Research UK Convergence Science Centre Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Organoid Biobank Product
Table 74. Thermo Fisher Scientific Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Corning Company Details
Table 77. Corning Business Overview
Table 78. Corning Organoid Biobank Product
Table 79. Corning Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 80. Corning Recent Development
Table 81. STEMCELL Technologies Company Details
Table 82. STEMCELL Technologies Business Overview
Table 83. STEMCELL Technologies Organoid Biobank Product
Table 84. STEMCELL Technologies Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 85. STEMCELL Technologies Recent Development
Table 86. Lonza Company Details
Table 87. Lonza Business Overview
Table 88. Lonza Organoid Biobank Product
Table 89. Lonza Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. Prellis Biologics Company Details
Table 92. Prellis Biologics Business Overview
Table 93. Prellis Biologics Organoid Biobank Product
Table 94. Prellis Biologics Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 95. Prellis Biologics Recent Development
Table 96. Amsbio Company Details
Table 97. Amsbio Business Overview
Table 98. Amsbio Organoid Biobank Product
Table 99. Amsbio Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 100. Amsbio Recent Development
Table 101. Cellesce Company Details
Table 102. Cellesce Business Overview
Table 103. Cellesce Organoid Biobank Product
Table 104. Cellesce Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 105. Cellesce Recent Development
Table 106. DefiniGEN Company Details
Table 107. DefiniGEN Business Overview
Table 108. DefiniGEN Organoid Biobank Product
Table 109. DefiniGEN Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 110. DefiniGEN Recent Development
Table 111. 3Dnamics Inc. Company Details
Table 112. 3Dnamics Inc. Business Overview
Table 113. 3Dnamics Inc. Organoid Biobank Product
Table 114. 3Dnamics Inc. Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 115. 3Dnamics Inc. Recent Development
Table 116. Organoid Therapeutics Company Details
Table 117. Organoid Therapeutics Business Overview
Table 118. Organoid Therapeutics Organoid Biobank Product
Table 119. Organoid Therapeutics Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 120. Organoid Therapeutics Recent Development
Table 121. InSphero Company Details
Table 122. InSphero Business Overview
Table 123. InSphero Organoid Biobank Product
Table 124. InSphero Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 125. InSphero Recent Development
Table 126. AIVITA Biomedical Company Details
Table 127. AIVITA Biomedical Business Overview
Table 128. AIVITA Biomedical Organoid Biobank Product
Table 129. AIVITA Biomedical Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 130. AIVITA Biomedical Recent Development
Table 131. JangoBio Company Details
Table 132. JangoBio Business Overview
Table 133. JangoBio Organoid Biobank Product
Table 134. JangoBio Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 135. JangoBio Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Organoid Biobank Picture
Figure 2. Global Organoid Biobank Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Organoid Biobank Market Share by Type: 2024 VS 2031
Figure 4. Tissue Derived Organoids Features
Figure 5. Pluripotent Stem Cell-derived Organoids Features
Figure 6. Global Organoid Biobank Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Organoid Biobank Market Share by Application: 2024 VS 2031
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Academics and Research Institutes Case Studies
Figure 11. Organoid Biobank Report Years Considered
Figure 12. Global Organoid Biobank Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Organoid Biobank Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Organoid Biobank Market Share by Region: 2024 VS 2031
Figure 15. Global Organoid Biobank Market Share by Players in 2024
Figure 16. Global Top Organoid Biobank Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Organoid Biobank Revenue in 2024
Figure 18. North America Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Organoid Biobank Market Share by Country (2020-2031)
Figure 20. United States Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Organoid Biobank Market Share by Country (2020-2031)
Figure 24. Germany Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Organoid Biobank Market Share by Region (2020-2031)
Figure 32. China Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Organoid Biobank Market Share by Country (2020-2031)
Figure 40. Mexico Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Organoid Biobank Market Share by Country (2020-2031)
Figure 44. Turkey Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. FRANKFURT CANCER INSTITUTE Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 49. Crown Bioscience Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 50. HUB Organoids Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 51. Cancer Research UK Convergence Science Centre Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 53. Corning Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 54. STEMCELL Technologies Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 55. Lonza Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 56. Prellis Biologics Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 57. Amsbio Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 58. Cellesce Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 59. DefiniGEN Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 60. 3Dnamics Inc. Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 61. Organoid Therapeutics Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 62. InSphero Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 63. AIVITA Biomedical Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 64. JangoBio Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Organoid Biobank Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tissue Derived Organoids
Table 3. Key Players of Pluripotent Stem Cell-derived Organoids
Table 4. Global Organoid Biobank Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Organoid Biobank Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Organoid Biobank Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Organoid Biobank Market Share by Region (2020-2025)
Table 8. Global Organoid Biobank Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Organoid Biobank Market Share by Region (2026-2031)
Table 10. Organoid Biobank Market Trends
Table 11. Organoid Biobank Market Drivers
Table 12. Organoid Biobank Market Challenges
Table 13. Organoid Biobank Market Restraints
Table 14. Global Organoid Biobank Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Organoid Biobank Market Share by Players (2020-2025)
Table 16. Global Top Organoid Biobank Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2024)
Table 17. Ranking of Global Top Organoid Biobank Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Organoid Biobank Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Organoid Biobank, Headquarters and Area Served
Table 20. Global Key Players of Organoid Biobank, Product and Application
Table 21. Global Key Players of Organoid Biobank, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Organoid Biobank Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Organoid Biobank Revenue Market Share by Type (2020-2025)
Table 25. Global Organoid Biobank Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Organoid Biobank Revenue Market Share by Type (2026-2031)
Table 27. Global Organoid Biobank Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Organoid Biobank Revenue Market Share by Application (2020-2025)
Table 29. Global Organoid Biobank Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Organoid Biobank Revenue Market Share by Application (2026-2031)
Table 31. North America Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Organoid Biobank Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Organoid Biobank Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Organoid Biobank Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Organoid Biobank Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Organoid Biobank Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Organoid Biobank Market Size by Country (2026-2031) & (US$ Million)
Table 46. FRANKFURT CANCER INSTITUTE Company Details
Table 47. FRANKFURT CANCER INSTITUTE Business Overview
Table 48. FRANKFURT CANCER INSTITUTE Organoid Biobank Product
Table 49. FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 50. FRANKFURT CANCER INSTITUTE Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Organoid Biobank Product
Table 54. Merck Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Crown Bioscience Company Details
Table 57. Crown Bioscience Business Overview
Table 58. Crown Bioscience Organoid Biobank Product
Table 59. Crown Bioscience Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 60. Crown Bioscience Recent Development
Table 61. HUB Organoids Company Details
Table 62. HUB Organoids Business Overview
Table 63. HUB Organoids Organoid Biobank Product
Table 64. HUB Organoids Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 65. HUB Organoids Recent Development
Table 66. Cancer Research UK Convergence Science Centre Company Details
Table 67. Cancer Research UK Convergence Science Centre Business Overview
Table 68. Cancer Research UK Convergence Science Centre Organoid Biobank Product
Table 69. Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 70. Cancer Research UK Convergence Science Centre Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Organoid Biobank Product
Table 74. Thermo Fisher Scientific Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Corning Company Details
Table 77. Corning Business Overview
Table 78. Corning Organoid Biobank Product
Table 79. Corning Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 80. Corning Recent Development
Table 81. STEMCELL Technologies Company Details
Table 82. STEMCELL Technologies Business Overview
Table 83. STEMCELL Technologies Organoid Biobank Product
Table 84. STEMCELL Technologies Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 85. STEMCELL Technologies Recent Development
Table 86. Lonza Company Details
Table 87. Lonza Business Overview
Table 88. Lonza Organoid Biobank Product
Table 89. Lonza Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. Prellis Biologics Company Details
Table 92. Prellis Biologics Business Overview
Table 93. Prellis Biologics Organoid Biobank Product
Table 94. Prellis Biologics Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 95. Prellis Biologics Recent Development
Table 96. Amsbio Company Details
Table 97. Amsbio Business Overview
Table 98. Amsbio Organoid Biobank Product
Table 99. Amsbio Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 100. Amsbio Recent Development
Table 101. Cellesce Company Details
Table 102. Cellesce Business Overview
Table 103. Cellesce Organoid Biobank Product
Table 104. Cellesce Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 105. Cellesce Recent Development
Table 106. DefiniGEN Company Details
Table 107. DefiniGEN Business Overview
Table 108. DefiniGEN Organoid Biobank Product
Table 109. DefiniGEN Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 110. DefiniGEN Recent Development
Table 111. 3Dnamics Inc. Company Details
Table 112. 3Dnamics Inc. Business Overview
Table 113. 3Dnamics Inc. Organoid Biobank Product
Table 114. 3Dnamics Inc. Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 115. 3Dnamics Inc. Recent Development
Table 116. Organoid Therapeutics Company Details
Table 117. Organoid Therapeutics Business Overview
Table 118. Organoid Therapeutics Organoid Biobank Product
Table 119. Organoid Therapeutics Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 120. Organoid Therapeutics Recent Development
Table 121. InSphero Company Details
Table 122. InSphero Business Overview
Table 123. InSphero Organoid Biobank Product
Table 124. InSphero Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 125. InSphero Recent Development
Table 126. AIVITA Biomedical Company Details
Table 127. AIVITA Biomedical Business Overview
Table 128. AIVITA Biomedical Organoid Biobank Product
Table 129. AIVITA Biomedical Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 130. AIVITA Biomedical Recent Development
Table 131. JangoBio Company Details
Table 132. JangoBio Business Overview
Table 133. JangoBio Organoid Biobank Product
Table 134. JangoBio Revenue in Organoid Biobank Business (2020-2025) & (US$ Million)
Table 135. JangoBio Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Organoid Biobank Picture
Figure 2. Global Organoid Biobank Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Organoid Biobank Market Share by Type: 2024 VS 2031
Figure 4. Tissue Derived Organoids Features
Figure 5. Pluripotent Stem Cell-derived Organoids Features
Figure 6. Global Organoid Biobank Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Organoid Biobank Market Share by Application: 2024 VS 2031
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Academics and Research Institutes Case Studies
Figure 11. Organoid Biobank Report Years Considered
Figure 12. Global Organoid Biobank Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Organoid Biobank Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Organoid Biobank Market Share by Region: 2024 VS 2031
Figure 15. Global Organoid Biobank Market Share by Players in 2024
Figure 16. Global Top Organoid Biobank Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Organoid Biobank Revenue in 2024
Figure 18. North America Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Organoid Biobank Market Share by Country (2020-2031)
Figure 20. United States Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Organoid Biobank Market Share by Country (2020-2031)
Figure 24. Germany Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Organoid Biobank Market Share by Region (2020-2031)
Figure 32. China Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Organoid Biobank Market Share by Country (2020-2031)
Figure 40. Mexico Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Organoid Biobank Market Share by Country (2020-2031)
Figure 44. Turkey Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Organoid Biobank Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. FRANKFURT CANCER INSTITUTE Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 49. Crown Bioscience Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 50. HUB Organoids Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 51. Cancer Research UK Convergence Science Centre Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 53. Corning Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 54. STEMCELL Technologies Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 55. Lonza Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 56. Prellis Biologics Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 57. Amsbio Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 58. Cellesce Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 59. DefiniGEN Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 60. 3Dnamics Inc. Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 61. Organoid Therapeutics Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 62. InSphero Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 63. AIVITA Biomedical Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 64. JangoBio Revenue Growth Rate in Organoid Biobank Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232